Tali Kizhner
Director of Manufacturing NurExone
Dr. Tali Kizhner is the Director of Research and Development at NurExone Biologic, where she leads development of exosome-based therapies for central nervous system injuries. She brings more than 15 years of experience in biologics research, chemistry, manufacturing, and process development across the biopharmaceutical industry. Before joining NurExone, she held leadership and scientific roles at Biond Biologics, International Flavors & Fragrances (IFF), and Protalix Biotherapeutics, contributing to FDA- and EMA-approved therapies for Fabry disease. Dr. Kizhner earned her Ph.D. in Biotechnology and Food Engineering from the Technion – Israel Institute of Technology and completed postdoctoral research focused on mesenchymal progenitor cells.
Seminars
- Identifying and controlling critical quality attributes such as particle size distribution, cargo composition, and surface markers to ensure consistent product identity
- Developing robust analytical assays for release testing and in-process monitoring to detect variability early in manufacturing
- Linking manufacturing controls to functional potency to maintain reproducible biological activity across batches
